CV Sciences Inc (OTC QB: CVSI) is a hemp-derived cannabinoid consumer products company that manufactures and sells plant-based food products, including hemp-derived CBD products, under its own brands. Revenue is generated through transactional product sales, with an online commerce channel alongside other distribution. The company operates out of a leased office and warehouse in San Diego, California, and a manufacturing facility in Grand Junction, Colorado (as of December 31, 2025). CV Sciences holds a granted patent covering methods of treating smokeless tobacco addiction using pharmaceutical formulations containing CBD and nicotine, issued by the USPTO on May 19, 2020, and granted in 10 countries as of December 31, 2025. The company faces a material regulatory threat: the November 2025 Appropriations Act revises the federal hemp definition to a total THC cap of 0.4 milligrams per container, with changes taking effect November 12, 2026, which would severely restrict the sale of a substantial majority of hemp-derived products the company currently sells. Joseph D. Dowling serves as Chief Executive Officer. The company does not pay cash dividends and carries senior secured debt obligations.

Revenue model

Transactional product sales of hemp-derived cannabinoid consumer products, including plant-based food products sold online and through other channels.

Products and services

Hemp-derived CBD consumer products; plant-based food products sold domestically and internationally; pharmaceutical candidate CVSI-007 (CBD and nicotine formulation for smokeless tobacco addiction, patent granted in 10 countries as of December 31, 2025); Elevated Softgels branded product line manufactured at the Grand Junction, Colorado facility.

Customers and end markets

End consumers purchasing hemp-derived cannabinoid and plant-based food products online and through retail channels. International sales subject to food safety, data privacy, and anti-corruption regulations including EU GDPR. No specific customer concentration data disclosed in the excerpts.

Value-chain role

Manufacturer and branded seller of hemp-derived consumer products. Operates leased manufacturing space (approximately 7,200 square feet in Grand Junction, Colorado as of February 2025) and leased office and warehouse space (approximately 6,000 square feet in San Diego, California as of December 31, 2025). Relies on third-party vendors for manufacturing, logistics, and shipping under cancelable contracts.

Geographic exposure

Primary operations in the United States (San Diego, California and Grand Junction, Colorado). International product sales subject to EU and other jurisdictions' food safety and data privacy regulations. Patent protection in 10 countries including the United States, Australia, Canada, Germany, Spain, France, Great Britain, Italy, Netherlands, and Japan (as of December 31, 2025).

Source: SEC 10-K, filed 2026-03-26

Industry: Pharmaceutical Preparations Peers: Merion, Inc. Estee Lauder Companies Inc Guardion Health Sciences, Inc. LiveWire Ergogenics, Inc. MusclePharm Corp RELIV INTERNATIONAL INC Horizon Kinetics Holding Corp